We serve Chemical Name:(2-methyloxazol-4-yl)methanol CAS:141567-53-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:(2-methyloxazol-4-yl)methanol
CAS.NO:141567-53-5
Synonyms:2-methyl-oxazole-4-methanol;4-Oxazolemethanol, 2-methyl-;(2-methyloxazol-4-yl)methanol;(2-Methyl-1,3-oxazol-4-yl)methanol;2-Methyl-4-oxazolemethanol;4-hydroxymethyl-2-methyloxazole
Molecular Formula:C5H7NO2
Molecular Weight:113.115
HS Code:2934999090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:208.1±15.0 °C at 760 mmHg
Density:1.2±0.1 g/cm3
Index of Refraction:1.496
PSA:46.26000
Exact Mass:113.047676
LogP:-1.01
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 2-methyl-oxazole-4-methanol chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4-hydroxymethyl-2-methyloxazole physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,(2-methyloxazol-4-yl)methanol Use and application,(2-Methyl-1,3-oxazol-4-yl)methanol technical grade,usp/ep/jp grade.
Related News: A week before Eli Lilly (LLY.N) disclosed to regulators that the U.S. Justice Department was investigating its New Jersey factory, the drugmaker told employees that its own inquiry, led by an outside law firm, found no evidence of wrongdoing there, according to a company memo reviewed by Reuters. (2-methyloxazol-4-yl)methanol manufacturer Same as Imbruvica’s original monotherapy use, the Venclexta combo offers a convenient oral treatment, while the drug’s two other approved cocktails—with Gazyva or Roche’s Rituxan—involve infusions. (2-methyloxazol-4-yl)methanol supplier China’s pharmaceutical CMO market has recently maintained a growth rate of more than 10%. From the perspective of market structure, the average growth rate of clinical production is 9.5%, while the average growth rate of commercial production will reach 18.7%. (2-methyloxazol-4-yl)methanol vendor The foundational patent, which expires in 2034, is owned by MSK and is licensed exclusively to Fate Therapeutics for all human therapeutic uses. (2-methyloxazol-4-yl)methanol factory China’s pharmaceutical CMO market has recently maintained a growth rate of more than 10%. From the perspective of market structure, the average growth rate of clinical production is 9.5%, while the average growth rate of commercial production will reach 18.7%.
